S350-0784 Screening compound: 2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-phenylacetamide

S350-0784 Screening compound: 2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-phenylacetamide
S350-0784 Screening compound: 2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S350-0784
2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S350-0784

Molecular Formula

C22H21N3O5 (C22 H21 N3 O5)

Compound Name

2-[4-(2-ethoxyphenyl)-2,5-dioxo-1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidin-1-yl]-N-phenylacetamide

IUPAC name

2-[4-(2-ethoxyphenyl)-25-dioxo-1H2H3H4H5H7H-furo[34-d]pyrimidin-1-yl]-N-phenylacetamide

SMILES

CCOc1c(C(C(C(OC2)=O)=C2N2CC(Nc3ccccc3)=O)NC2=O)cccc1

InChI

InChI=1S/C22H21N3O5/c1-2-29-17-11-7-6-10-15(17)20-19-16(13-30-21(19)27)25(22(28)24-20)12-18(26)23-14-8-4-3-5-9-14/h3-11,20H,2,12-13H2,1H3,(H,23,26)(H,24,28)/t20-/m0/s1

InChI Key

ZLLGCYGOLWGZKE-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD29000402

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.748

Distribution Coefficient, logD

2.747

Water Solubility, LogSw

-3.18

Polar Surface Area

80.751

Acid Dissociation Constant (pKa)

10.03

Base Dissociation Constant (pKb)

0.69

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.70

S350-0784 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S350-0784 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S350-0784?
Check Price and Availability of S350-0784, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S350-0784 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S350-0784
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S350-0784
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S350-0784 available by request